Price movement over the last 24 hours
ARK Genomic Revolution ETF vs ServiceNow Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while ServiceNow Inc trades at $108.82 (market cap $111.08B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ServiceNow Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | NOW | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $199.24 |
52-Week Low | $23.09 | $83.00 |
Market Cap | — | $111.08B |
Enterprise Value | — | $108.33B |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ServiceNow (NOW) trades at $107.71, down 1.04% today, with a bullish technical outlook from moving averages and strong fundamental growth. Revenue grew from $7.2B in 2022 to $13.3B in 2025, with net income reaching $1.75B. The stock shows robust cash flow generation and high profitability margins, though valuation multiples remain elevated. Recent news highlights AI-driven growth opportunities and conference presentations reinforcing business momentum.
Outlook remains positive with 85.5% analyst buy ratings and a $138.39 consensus target, implying 28% upside. Key risks include high P/E of 64.11, competitive pressures in enterprise software, and execution challenges in scaling AI offerings. Earnings consistency and margin sustainability are critical for maintaining premium valuation amid market volatility.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →